Evidence map›Paper›PMID 42185405›Full record

ArticleScientific reports2026

Thymoquinone protects against statin-induced cerebellar damage, apoptosis, and hepatic cytotoxicity in rats.

Salwa M Ouies, Yahia A Amin, Noha A Ragab, Zahraa M Ismae, Mohamed A Hassany, Basma T Abd Elhameed, Rehab G M Hassan, Walaa I Mohammed, Maha Abd-El Baki Ahmed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Salwa M OuiesDepartment of Human Anatomy and Embryology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Yahia A AminDepartment of Theriogenology, Faculty of Veterinary Medicine, Aswan University, Aswan, 81528, Egypt. dr.yahiaamin@vet.aswu.edu.eg.ORCID http://orcid.org/0000-0003-4075-2664
Noha A RagabDepartment of Human Anatomy and Embryology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Zahraa M IsmaeDepartment of Human Anatomy and Embryology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Mohamed A HassanyDepartment of Internal Medicine, Faculty of Medicine, Aswan University, Aswan, Egypt.
Basma T Abd ElhameedDepartment of Pathology, Faculty of Medicine, South valley University, Qena, Egypt.
Rehab G M HassanDepartment of Public Health, Faculty of Medicine, South Valley University, Qena, Egypt.
Walaa I MohammedDepartment of Clinical Pharmacology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Maha Abd-El Baki AhmedDepartment of Human Anatomy and Embryology, Faculty of Medicine, South Valley University, Qena, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are a class of drugs commonly prescribed to lower cholesterol and low-density lipoprotein (LDL) cholesterol levels, as well as to reduce morbidity and mortality associated with cardiovascular illnesses. However, statins are associated with potential side effects, such as muscle pain, liver problems, and neurological or psychiatric disturbances. Therefore, a protective medication is required to mitigate the harmful effects of statins. Thymoquinone (THQ), found in Nigella sativa, has several medicinal benefits and protective effects. The current study aimed to investigate the effects of simvastatin on cerebellar and hepatic tissues, focusing on cellular apoptosis, using light and electron microscopy, morphometric analysis, and immunohistochemical techniques. Additionally, the study evaluates whether thymoquinone can protect against simvastatin-induced histological and ultrastructural damage in hepatic and cerebellar tissues. Thirty adult male Wistar albino rats were divided into three equal groups. Group I was the control group (Ctrl group). Group II (statin group) received simvastatin (20 mg/kg/day) orally for 8 weeks. Group III (statin + THQ group) received concomitant treatment with simvastatin (20 mg/kg/day) and thymoquinone (10 mg/kg/day) for 8 weeks. Tissue specimens were taken from the liver and cerebellum of all animal groups and processed for light and electron microscopic examination. An immunohistochemical investigation for caspase-3 was performed. The molecular and granular layer thickness, number of Purkinje cells, central vein diameter, hepatocyte nuclear diameter, and optical density of anti-caspase-3-positive cells were measured in both the cerebellum and the liver in all experimental groups. Results showed that cerebellum from simvastatin-treated animals showed perinuclear halos in cells within the molecular layer. Purkinje cells appeared disorganized, irregularly arranged, shrunken, with irregular outlines, hyperchromatic nuclei, and vacuolated cytoplasm. Moreover, the granular cell layer appeared shrunken with irregular hyperchromatic nuclei. In addition, decreased thickness of both the molecular and granular layers, as well as a reduction in the number and diameter of Purkinje cells, was observed and confirmed by morphometric analysis. Liver tissue showed shrunken hepatocytes, widened blood sinusoids, widened central veins, and inflammatory cell infiltration. Furthermore, strong positive expression of caspase-3 was observed in both the cerebellum and liver. However, all these histological, ultrastructural, and morphometric changes were markedly decreased after the addition of thymoquinone. It can be concluded that simvastatin induces significant degeneration in both the cerebellar cortex and liver tissue, primarily due to increased oxidative stress and reduced antioxidant protection. Thymoquinone exerts protective effects against this oxidative damage in both organs and alleviates degenerative changes, suggesting that it may be recommended for hypercholesterolemic patients on statins.

Indexed as

ApoptosisBenzoquinonesCerebellumChemical and Drug Induced Liver InjuryHydroxymethylglutaryl-CoA Reductase InhibitorsLiverProtective AgentsSimvastatinAnimalsCaspase 3MaleRatsRats, WistarBenzoquinonesCaspase 3Hydroxymethylglutaryl-CoA Reductase InhibitorsProtective AgentsSimvastatinthymoquinoneCerebellumLiverSimvastatinThymoquinone

Identifiers

PMID42185405
PMCPMC13219537

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.